Silodosin-induced anejaculation a potential treatment for postorgasmic illness syndrome
Silodosin, which helps patients achieve anejaculation, may be an effective treatment for postorgasmic illness syndrome (POIS), a recent study has found. Nevertheless, POIS remains an understudied condition with debilitating consequences on patients and their partners, underscoring the need for further investigations.
